Relay Therapeutics is up a bit on the day, funds flowing in kept the price up 2.37% since yesterday.
Currently RLAY isn't at a clear support/resistance line that seems tradable. Relay Therapeutics hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. RLAY might find some support at the 5.635 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts are pretty neutral on Relay Therapeutics right now, so not much useful information here. The current Analysts Sentiment Score is 0.84. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. HC Wainwright announced a lowering of their price target to $17.00 from $19.00 on 2023-12-11. Oppenheimer reiterated a rating of Outperform on 2023-08-09 and added a price target of $33.00. SVB Securities initiated a rating of Outperform on 2023-08-08. Leerink Partnrs reiterated a rating of Outperform on 2023-08-08. JMP Securities announced a lowering of their price target to $24.00 from $28.00 on 2023-05-05. On 2023-04-20 Stifel Nicolaus lowered their price target by -10.53% to $34.00. Jefferies Financial Group upgraded from Underperform to Hold on 2023-04-20 but they lowered their price target by -21.88% to $12.50 from a previous target of $16.00. On 2023-04-19 Barclays lowered their price target by -34.78% to $15.00. Raymond James upgraded from Outperform to Strong-Buy on 2023-04-19 and added a price target of $29.00. JPMorgan Chase & Co. provided a price target decease of -30.95% to $29.00 from $42.00 on 2023-04-19.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| RLAY | 0.84 | 1.88 | 0 | 0.71 | -0.92 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| RLAY | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| RLAY | 11.39 | %16.3 | 13.5 | -40.524 | 13770000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| RLAY |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LMND | Lemonade, Inc. | 0.88 | -2.14 | 43.63 | 164.38 | 165.95 | 199.57 | 191.60 | 76 | 23.62 | 21.59 | 20.11 | 0.00 | -21804.06 | 125 | 0 | 23.9383 |
| SAGE | Sage Therapeutics, Inc | 0.86 | 6.60 | 8.16 | -39.46 | -38.67 | -56.66 | -73.49 | 31 | -168.21 | -178.82 | -69.30 | -149709.64 | -1968.67 | 0 | 0 | 12.6533 |
| CRSP | CRISPR Therapeutics AG | 0.86 | 3.43 | 1.23 | -3.68 | 0.34 | -12.69 | -31.57 | 56 | -22.71 | -24.19 | -28.44 | -6526.20 | -3384.34 | 0 | 0 | 15.3247 |
| TDOC | Teladoc Health, Inc. | 0.85 | 2.12 | 17.35 | 15.69 | 48.12 | -6.51 | -38.79 | 62 | -19.65 | -26.21 | -29.67 | 303.43 | -4064.44 | 0 | 0 | 8.78425 |
| EDIT | Editas Medicine, Inc. Com | 0.83 | 2.95 | -3.17 | -25.15 | -34.76 | -54.14 | -76.94 | 47 | -172.46 | -138.74 | -176.20 | -57394.91 | 2.09 | 0 | 0 | 16.4101 |
| YMAB | Y-mAbs Therapeutics, Inc. | 0.83 | 3.07 | -2.89 | -29.71 | -27.25 | -14.25 | 91.36 | 24 | 9.59 | 32.38 | 48.32 | -2113.67 | -19525.09 | 0 | 0 | 10.5121 |
| FATE | Fate Therapeutics, Inc. | 0.82 | -3.85 | -21.88 | -36.51 | -47.92 | -48.85 | -15.97 | 33 | -68.94 | -30.14 | -33.88 | -32112.58 | -931.66 | 0 | 0 | 7.69285 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
